NextRNA Therapeutics, Inc. is a MA-based newly founded biotechnology company committed to leading the next revolution of RNA-directed therapeutics. Based on the foundational work of Carl Novina at Dana-Farber Cancer Institute, NextRNA has established a proprietary target and drug discovery engine that enables us to systematically identify disease-relevant long non-coding RNAs and their interacting proteins, and develop selective small molecules to drug RNA-protein interactions.
The company is currently advancing two small molecule therapeutic programs in oncology and immunology.
NextRNA has assembled a highly experienced and competent team of industry leaders, biology and chemistry experts, and drug developers, all driven by a common passion for working together and having an impact on science and patients.
Location: United States, Massachusetts, Boston
Member count: 11-50
Total raised: $46.8M
Founded date: 2020
Investors 2
| Date | Name | Website |
| - | Lightchain... | lightchain... |
| - | Cobro Vent... | cobroventu... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 01.03.2022 | Series A | $46.8M | Lightchain... | - |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 01.03.2022 | NextRNA Th... | NextRNA Therapeutics, a Cambri... | USA | - | finsmes.co... |